CD24 and hepatocellular carcinoma: The DCs cytokine-induced killer (CIK) cells loaded with the CD24 peptide (DC/CIK-CD24) were utilized as immunotherapies for primary HCC patients who underwent radical resection in another single-arm, single-institution phase I/II clinical research [57].